Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
Clinical trial NCT01278160 · COMPLETED
Trial details
- NCT number
- NCT01278160
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-09-01
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.